Histologically, a loss of E-cadherin is more commonly observed in poorly differentiated PDAC [54,55,56,57] while in contrast, 45% of PDAC cases had vimentin expressed in 1–95% of cancer cells, and 27.5% had vimentin expressed in 10% or more of the cancer cells [58]. This evidence concerns the gene VIM and cancer.